Pfg Advisors Charles River Laboratories International, Inc. Transaction History

Pfg Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$182.44 - $250.54 $10,034 - $13,779	-55 Reduced 4.95%	1,055 $208,000
Q2 2022 Jul 13, 2022	SELL	$204.13 - $302.4 $14,289 - $21,168	-70 Reduced 5.93%	1,110 $238,000
Q1 2022 Apr 19, 2022	SELL	$255.51 - $362.11 $518,685 - $735,083	-2,030 Reduced 63.24%	1,180 $335,000
Q4 2021 Jan 21, 2022	BUY	$351.38 - $448.68 $1.13 Million - $1.44 Million	3,210 New	3,210 $1.21 Million

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

Stay updated on Pfg Advisors with notifications on news.